Evidence map›Paper›PMID 30726112›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism.

Isabel González-Mariscal, Rodrigo A Montoro, Jennifer F O'Connell, Yoo Kim, Marta Gonzalez-Freire, Qing-Rong Liu, Irene Alfaras, Olga D Carlson, Elin Lehrmann, Yongqing Zhang and 4 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Genetic Tools in Rodents to Study Cannabinoid Functions.Current topics in behavioral neurosciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Hepatic targeting of the centrally active cannabinoid 1 receptor (CBJournal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  11. The Peripheral Cannabinoid Receptor Type 1 (CBMolecules (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Isabel González-MariscalLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Rodrigo A MontoroLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Jennifer F O'ConnellLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Yoo KimLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Marta Gonzalez-FreireTranslational Gerontology Branch, National Institute on Aging (NIA), National Institutes of Health, Baltimore, Maryland, USA.
Qing-Rong LiuLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Irene AlfarasTranslational Gerontology Branch, National Institute on Aging (NIA), National Institutes of Health, Baltimore, Maryland, USA.
Olga D CarlsonLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Elin LehrmannLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Yongqing ZhangLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Kevin G BeckerLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Stéphan HardivilléUnité Propre de Recherche (UMR) 8576-Unité de Glycobiologie Structurale et Fonctionelle (UGSF), Centre National de la Recherche (CNRS), Université Lille, Lille, France.
Paritosh GhoshLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
Josephine M EganLaboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health (NIH), Baltimore, Maryland, USA.
National Institutes of Health · USNational Institute on Aging · USUnité de Glycobiologie Structurale et Fonctionnelle · FR

Funding

Analysis of complex biological systems by microarray based gene expressionZICAG000616 · NIA · NATIONAL INSTITUTE ON AGING · PI DE, SUPRIYO · 2009 to 2025
$15.5M
6 · The paper itself

Abstract

Sarcopenic obesity, the combination of skeletal muscle mass and function loss with an increase in body fat, is associated with physical limitations, cardiovascular diseases, metabolic stress, and increased risk of mortality. Cannabinoid receptor type 1 (CB1R) plays a critical role in the regulation of whole-body energy metabolism because of its involvement in controlling appetite, fuel distribution, and utilization. Inhibition of CB1R improves insulin secretion and insulin sensitivity in pancreatic β-cells and hepatocytes. We have now developed a skeletal muscle-specific CB1R-knockout (Skm-CB1R

Indexed as

Signal TransductionAgingAnimalsBody CompositionBody WeightCell LineDietFemaleHepatocytesInsulinInsulin ResistanceIntercellular Signaling Peptides and ProteinsInterleukin-6MaleMiceMice, KnockoutCNR1 protein, mouseInsulinIntercellular Signaling Peptides and ProteinsInterleukin-6interleukin-6, mouseMstn protein, mouseMyostatinPhosphoproteinsReceptor, Cannabinoid, CB1CB1Rinsulin sensitivitymyokinesskeletal muscle

Identifiers

PMID30726112
PMCPMC6988864
OpenAlexW2913493797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.